Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.
Bladder cancer is the fourth most common cancer in men in the U.S. and the 10th most common in women. It usually occurs in patients over 68 years of age, so a noninvasive way to evaluate cases in elderly patients could lower risks of complications.
Dr. Ercan Kocakoc and colleagues in the departments of radiology and urology at Firat University in Elazig, Turkey, published their study in the January issue of the Journal of Ultrasound in Medicine. They examined 31 patients with confirmed or suspected bladder cancer using 3D ultrasound within 15 days of conventional cystoscopy and compared the results.
Each ultrasound exam included gray-scale, 3D virtual, and multiplanar reconstruction images, which the researchers evaluated for the number, size, location, and morphologic features of lesions, providing a virtual cystoscopy.
The researchers obtained good or excellent image quality on 28 of the 31 virtual cystoscopies, or 90.3%. Conventional cystoscopy found 47 lesions in 22 patients. Virtual cystoscopy showed 41 or 87.2% of these 47 lesions.
For tumor detection, 3D sonography alone had a 96.2% sensitivity, 70.6% specificity, positive predictive value of 93.9%, and negative predictive value of 80%. A combination of gray-scale sonography, multiplanar reconstruction, and 3D virtual sonography detected tumors with a sensitivity of 96.4%, specificity of 88.8%, positive predictive value of 97.6%, and negative predictive value of 84.2%.
The researchers concluded that 3D ultrasound could be a promising noninvasive alternative to conventional methods of detecting bladder cancer, since the results of virtual cystoscopy agreed well with conventional cystoscopy.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.